Riskpilot← Back to searchSign inGet full accessBLOMSTERVEGEN 1 AS
ASActiveOrg 927501015Melhusvegen 720, 7224 MelhusBuying and selling of own real estate · NACE 6811Est. 20210 employees
Revenue 2025
NOK 42,3M
+317% vs 2024
EBITDA margin
8.6%
+221% vs 2024
Equity ratio
11.2%
Financial strength
Net profit 2025
NOK 1,2M
+52% vs 2024
| Revenue | NOK 42,3M | +317% |
| EBITDA | NOK 3,6M | +221% |
| Net profit | NOK 1,2M | +52% |
| Total assets | NOK 7,7M | -44% |
| Equity | NOK 856K | +41% |
| Employees | 0 | — |
Legal name
BLOMSTERVEGEN 1 AS
Org number
927501015
Legal form
Aksjeselskap
NACE code
6811 · Buying and selling of own real estate
Founded
4. august 2021
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Kjøp og salg av eiendom med henblikk på utbygging og utleie, samt det som står i forbindelse med dette.
Address
Melhusvegen 720, 7224 Melhus
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 10 146 | 42 273 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −4 | −56 | −17 | 1 137 | 3 643 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −4 | −56 | −17 | 1 137 | 3 643 |
| Net financials | 0 | −81 | −84 | −148 | −2 012 |
| Profit before tax | −4 | −137 | −101 | 989 | 1 631 |
| Tax | −0 | −0 | −0 | 164 | 382 |
| Net profit | −4 | −137 | −101 | 824 | 1 249 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 449 | 2 761 | 2 959 | 13 614 | 7 667 |
| Equity | 20 | −117 | −218 | 607 | 856 |
| Long-term debt | 2 422 | 2 803 | 3 087 | 164 | 0 |
| Short-term debt | 7 | 75 | 91 | 12 844 | 6 810 |
| Total debt | 2 428 | 2 878 | 3 177 | 13 008 | 6 810 |
EBITDA margin
8.6%
This company
15.8%
Market median
-46% vs market
20212025
Equity ratio
11.2%
This company
38.2%
Market median
-71% vs market
20212025
Return on equity
145.9%
This company
18.4%
Market median
+693% vs market
20212025
Net profit margin
3.0%
This company
8.1%
Market median
-63% vs market
20212025
Asset turnover
5.51×
This company
1.12×
Market median
+392% vs market
20212025
Debt / equity
7.96×
This company
0.62×
Market median
-1184% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KE Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 75% | 75% | 2024 | |
| Company | 25% | 25% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Shankia As
BLOMSTERVEGEN 1 AS Board members of BLOMSTERVEGEN 1 AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kent Erik Bjerkenås | Chief Executive Officer | 0 companies |
| Idar Bjerkenås | Board of Directors | 0 companies |
| Jon Erik Lund | Board of Directors | 0 companies |